https://www.selleckchem.com/pr....oducts/bgb-283-bgb28
2-333.3%). Further, concomitant glucocorticoid administration was a significant protective factor for reducing serum concentration (OR 0.16, 95% CI 0.03-0.79, p=0.025). Switching from intravenous to oral treatment resulted in a significant decline in voriconazole trough concentrations with wide inter-individual variability. Therefore, measurement of serum concentration for dose adjustment should be performed after switching to the oral form. Switching from intravenous to oral treatment resulted in a significant decline in voricon
Like
Comment
Share
